Article Versions Notes

Köhler B, Dubovik S, Hörterer E, Wilk U, Stöckl JB, Tekarslan-Sahin H, Ljepoja B, Paulitschke P, Fröhlich T, Wagner E, et al. Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification. Cancers. 2022; 14(22):5554. https://doi.org/10.3390/cancers14225554

Köhler, Bianca, Sviatlana Dubovik, Elisa Hörterer, Ulrich Wilk, Jan Bernd Stöckl, Hande Tekarslan-Sahin, Bojan Ljepoja, Philipp Paulitschke, Thomas Fröhlich, Ernst Wagner, and et al. 2022. "Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification" Cancers 14, no. 22: 5554. https://doi.org/10.3390/cancers14225554

Köhler, B., Dubovik, S., Hörterer, E., Wilk, U., Stöckl, J. B., Tekarslan-Sahin, H., Ljepoja, B., Paulitschke, P., Fröhlich, T., Wagner, E., & Roidl, A. (2022). Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification. Cancers, 14(22), 5554. https://doi.org/10.3390/cancers14225554